Plain-English translation of NCT03193476 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a long-term registry — essentially a patient database — that collects health information from people of all ages who have X-linked hypophosphatemia (XLH), a rare genetic condition that affects how the body handles phosphate and impacts bone health. Researchers will track your medical history, current treatments, and how you're doing over time to understand how XLH develops and progresses, and how well different treatments work. This information will help doctors learn more about the condition and improve care for future patients.
XLH is a rare condition, so doctors need to gather real-world information from as many patients as possible to understand its long-term effects and how people respond to treatment. This registry also helps monitor the safety of available medications used to treat the condition.
You likely qualify if…
You likely don't qualify if…
You will be invited to join the registry at a participating clinic and provide consent (or have your parent or guardian do so). From that point, your medical team will share information about your diagnosis, treatments, test results, and health outcomes with the registry over time. There is no experimental treatment involved — you simply continue your normal care while your information is collected to help researchers understand your condition better.
AI-generated summary from trial data · Sep 24, 2026 · Not medical advice
Belgium